Vanmiddag nam minister Jan Anthonie Bruijn van het ministerie van Volksgezondheid, Welzijn en Sport in Leiden, bij het LUMC, het rapport ‘Nederland in de voorhoede: rode biotech als sleutel tot wereldwijde concurrentiekracht; een groeistrategie voor economie, maatschappij en patiënt’ in…
Two Zuid-Holland startups are bringing breakthrough technology into clinical practice. Axite from Leiden and Hologenomix from Delft each receive a €350,000 investment from the proof-of-concept fund UNIIQ to further develop their innovations and bring them to market. Axite: at-home brain monitoring for everyone with a brain condition…
How can we slow down atherosclerosis? Researcher Amanda Foks believes it may be possible by targeting aged immune cells. This could lead to an entirely new treatment for heart attacks and strokes. For this research, she has been awarded the…
Clinical Technology, the joint bachelor’s program offered by Erasmus MC, TU Delft, and LUMC, has once again received the “Top Program” designation from the Keuzegids Universiteiten. This recognition is partly based on evaluations submitted by students themselves. The 2026 edition…
Scientists have successfully tested a new medication that could represent a breakthrough in the treatment of heart disease. Researchers at Leiden University Medical Center (LUMC) have successfully tested a drug in mice that could transform the treatment of cardiovascular disease.…
Red biotechnology, including innovative medicines and therapies, vaccines, personalised diagnostics and advanced treatments, has the potential to become a cornerstone of the Dutch economy, combining economic growth with tangible health impact. National ambitions for red biotechnology At the request of…
December 8, 2025, The share of female professors is increasing, but the growth remains limited. With 34.2%, Leiden University ranks in the national top three, according to the 2025 Female Professors Monitor. At the end of 2024, the proportion of…
Leiden, December 6, 2025, 12:15 PM – by Robbert Beurse – Every day, around 70,000 people in the Netherlands experience a migraine attack. The condition ranks among the five most disabling diseases worldwide and can completely disrupt daily life. Researchers…
The meteorological winter has begun, and with it, the flu season. Yet there is hope: the Leiden-based biotech company Leyden Labs is working on a promising innovation that could drastically curb the annual wave of infections. The product is a…